# PHEMI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phemi

- Industry: Software
- Headquarters: Vancouver, Canada
- Website: www.phemi.com
- Total disclosed funding: $25M
- Latest round: Series B (Jun 27, 2017)
- Investors on record: 6

## About

PHEMI Inc is a data management solutions provider specializing in enhancing data accessibility and usability across various sectors, particularly in healthcare, finance, and technology.Founded in 2013 and headquartered in Vancouver, Canada, PHEMI Inc focuses on advanced data integration and analytics tools. The company has raised a total of USD 10.00 mn through 3 deals, with its most recent funding round being a Series B in June 2017, led by BDC Capital, CTI Life Sciences, GF Securities, Quark Venture, and Yaletown Partners.PHEMI specializes in innovative data management solutions designed to enhance data accessibility and usability for enterprises across various sectors. The primary offerings include advanced data integration and analytics tools that help organizations manage and analyze their data assets effectively. PHEMI's solutions are crucial in industries like healthcare, finance, and technology, where real-time data insights are essential for operational efficiency and decision-making. The company serves end users such as data scientists, analysts, and business leaders, focusing on markets in North America, Europe, and Asia-Pacific.PHEMI generates revenue through a structured model emphasizing direct-to-business transactions, utilizing subscription-based services and tailored partnerships. The company offers various pricing plans, including licensing fees for its flagship data management platform. Clients, primarily large enterprises, engage through multi-year contracts, ensuring access to a comprehensive suite of data analytics tools and ongoing support services. This model fosters long-term relationships and facilitates regular updates and enhancements, aligning with clients' evolving data strategies.PHEMI plans to leverage its recent Series B funding of USD 10.00 mn raised in June 2017 to support the development of new products and expand into new geographic regions. The company aims to introduce additional data management solutions targeting healthcare and finance sectors in North America and Europe by the end of 2023. The funding will be utilized to enhance product offerings and facilitate market entry into Asia-Pacific, aligning with its strategy to bolster its presence in data-driven industries.

## Funding rounds

- Series B, Jun 27, 2017, $10M — BDC Capital, Yaletown Partners, CTI Life Sciences, GF Securities, Quark Venture
- Series A, Aug 11, 2015, $12M — BDC Capital, Discovery Capital, Yaletown Partners, CTI Life Sciences
- Seed, Mar 24, 2014, $2.8M — BDC Capital, Yaletown Partners

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Seed, Series A, Series B
- Yaletown Partners (https://capitalatlas.ai/funds/yaletown-partners) — Seed, Series A, Series B
- Discovery Capital (https://capitalatlas.ai/funds/discovery-capital) — Series A
- CTI Life Sciences (https://capitalatlas.ai/funds/cti-life-sciences) — Series A, Series B
- GF Securities — Series B
- Quark Venture (https://capitalatlas.ai/funds/quark-venture) — Series B